drugset / Trial / NCT01486433
The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The primary objective is to determine the effect of multiple doses of Epanova® (omega fatty acids) on the pharmacokinetics (PK) of multiple 40 mg doses of simvastatin.
Timeline
- Start
- 2011-11
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Simvastatin | Small molecule | 40 mg | — |
| Subject | omefas | Unknown | 4 g | — |
| Background | Aspirin | Small molecule | 81 mg | — |